Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33)

hhslogoExpanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) – The purpose of this FOA is to solicit applications proposing to test approaches for expanding medication assisted treatment (MAT) for opioid use disorder (OUD) in the general health care sector or linking individuals with OUDs who receive naloxone for the reversal of overdose to MAT in the context of states plans for use of the funds authorized under the 21st Century Cures Act. Current Closing Date for Applications: June 20, 2017.

Advertisements